Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 74.50
-0.71 (-0.94%)
At close: Jan 22, 2026
SHE:300841 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1,105 | 1,326 | 1,577 | 1,446 | 1,292 | 1,039 | Upgrade |
Other Revenue | 106.25 | 106.25 | 0 | 0.32 | - | - | Upgrade |
| 1,212 | 1,432 | 1,577 | 1,447 | 1,292 | 1,039 | Upgrade | |
Revenue Growth (YoY) | -26.47% | -9.22% | 9.03% | 11.94% | 24.44% | 87.26% | Upgrade |
Cost of Revenue | 89.61 | 84.64 | 104.9 | 101.84 | 85.7 | 62.81 | Upgrade |
Gross Profit | 1,122 | 1,347 | 1,472 | 1,345 | 1,207 | 975.83 | Upgrade |
Selling, General & Admin | 695.85 | 658.4 | 601.15 | 510.78 | 498.42 | 444.98 | Upgrade |
Research & Development | 122.64 | 132.05 | 253.03 | 179.94 | 78.88 | 58.25 | Upgrade |
Other Operating Expenses | 10.84 | 9.99 | 9.24 | 8.23 | 7.14 | 6.7 | Upgrade |
Operating Expenses | 837.12 | 815.6 | 872.01 | 733.05 | 592.78 | 509.9 | Upgrade |
Operating Income | 284.82 | 531.64 | 600.49 | 611.84 | 613.96 | 465.92 | Upgrade |
Interest Expense | -4.27 | -5.38 | -4.81 | -3.19 | -0.07 | -0.23 | Upgrade |
Interest & Investment Income | 12.18 | 13.17 | 12.94 | 19.26 | 25.93 | 14.68 | Upgrade |
Currency Exchange Gain (Loss) | 1.68 | 1.68 | 0.21 | 0.05 | -0.01 | -0.06 | Upgrade |
Other Non Operating Income (Expenses) | -16.28 | -15.02 | -1.28 | -1.44 | -0.19 | -0.14 | Upgrade |
EBT Excluding Unusual Items | 278.14 | 526.1 | 607.54 | 626.53 | 639.62 | 480.18 | Upgrade |
Gain (Loss) on Sale of Investments | -49.82 | -59.73 | -31.6 | 51.89 | 269.32 | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.02 | -1.79 | -0.19 | - | -0.11 | -0.24 | Upgrade |
Asset Writedown | -6.27 | -0.02 | -0.3 | - | - | - | Upgrade |
Other Unusual Items | 4.21 | 2.45 | -1.47 | 5.37 | 6.75 | 4 | Upgrade |
Pretax Income | 226.24 | 467.02 | 573.99 | 683.79 | 915.58 | 483.94 | Upgrade |
Income Tax Expense | 44.38 | 68.37 | 64.78 | 85.73 | 86.1 | 75.89 | Upgrade |
Net Income | 181.86 | 398.65 | 509.22 | 598.07 | 829.48 | 408.05 | Upgrade |
Net Income to Common | 181.86 | 398.65 | 509.22 | 598.07 | 829.48 | 408.05 | Upgrade |
Net Income Growth | -66.70% | -21.71% | -14.86% | -27.90% | 103.28% | 118.57% | Upgrade |
Shares Outstanding (Basic) | 130 | 132 | 134 | 134 | 135 | 118 | Upgrade |
Shares Outstanding (Diluted) | 130 | 132 | 134 | 134 | 135 | 118 | Upgrade |
Shares Change (YoY) | -2.00% | -1.56% | -0.17% | -0.46% | 13.94% | 16.71% | Upgrade |
EPS (Basic) | 1.40 | 3.03 | 3.81 | 4.47 | 6.16 | 3.45 | Upgrade |
EPS (Diluted) | 1.40 | 3.03 | 3.81 | 4.46 | 6.16 | 3.45 | Upgrade |
EPS Growth | -66.02% | -20.47% | -14.71% | -27.57% | 78.42% | 87.29% | Upgrade |
Free Cash Flow | 377.25 | 427.94 | 416.71 | -224.24 | -184.61 | 233.9 | Upgrade |
Free Cash Flow Per Share | 2.90 | 3.25 | 3.12 | -1.67 | -1.37 | 1.98 | Upgrade |
Dividend Per Share | 1.000 | 1.000 | 2.000 | 0.500 | 1.000 | 0.667 | Upgrade |
Dividend Growth | -50.00% | -50.00% | 300.00% | -50.00% | 49.99% | - | Upgrade |
Gross Margin | 92.60% | 94.09% | 93.35% | 92.96% | 93.37% | 93.95% | Upgrade |
Operating Margin | 23.51% | 37.13% | 38.07% | 42.29% | 47.50% | 44.86% | Upgrade |
Profit Margin | 15.01% | 27.84% | 32.28% | 41.34% | 64.18% | 39.29% | Upgrade |
Free Cash Flow Margin | 31.14% | 29.89% | 26.42% | -15.50% | -14.28% | 22.52% | Upgrade |
EBITDA | 357.51 | 595.04 | 651.5 | 643.37 | 629 | 478.18 | Upgrade |
EBITDA Margin | 29.51% | 41.56% | 41.30% | 44.47% | 48.67% | 46.04% | Upgrade |
D&A For EBITDA | 72.69 | 63.4 | 51.02 | 31.53 | 15.04 | 12.26 | Upgrade |
EBIT | 284.82 | 531.64 | 600.49 | 611.84 | 613.96 | 465.92 | Upgrade |
EBIT Margin | 23.51% | 37.13% | 38.07% | 42.29% | 47.50% | 44.86% | Upgrade |
Effective Tax Rate | 19.62% | 14.64% | 11.29% | 12.54% | 9.40% | 15.68% | Upgrade |
Revenue as Reported | 1,212 | 1,432 | 1,577 | 1,447 | 1,292 | 1,039 | Upgrade |
Advertising Expenses | - | 445.06 | 398.03 | 346.56 | 344.4 | 327.89 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.